HHS is considering major cuts to federal HIV prevention funding as part of a CDC reorganization, potentially affecting programs like PrEP. Experts warn the move could hinder efforts to combat the ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

The pandemic stretched us—our communication, our science, our distribution networks, even what it means to be a good citizen ...

After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding.

Can the continent walk the talk? **** The African Union has embarked on one of its most audacious health security missions: ...

Human Immunodeficiency Virus (HIV) severely damages the immune system ... More research is needed on the structure, replication, persistence, and latency of HIV itself, as well as the characteristics ...

A preliminary study has found that efavirenz — a non-nucleoside inhibitor of HIV virus that is used for treating HIV/AIDS — can be repurposed for the treatment of chikungunya. Currently ...

Researchers have discovered that Daphne pseudomezereum (commonly known as Onishibari) contains a substance inhibiting ...

A research group led by Professor Wei Li from the Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Toho ...

Survey data suggests that over a third of organizations that relied on US funding for HIV services had already closed by ...

Annie Antar, MD, PhD, discusses how patients with HIV can have different and longer-lasting symptoms of COVID-19.

Annie Antar, MD, PhD, discusses the association between the symptoms of long COVID and HIV status. Annie Antar, MD, PhD, Johns Hopkins Medicine, spoke about how the likelihood of long COVID symptoms ...